Cyclic AMP and cyclic GMP levels in human colonic mucosa before and during chenodeoxycholic acid therapy

9Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Previous experimental studies suggest that bile salt-induced colonic fluid secretion is mediated by adenosine 3':5'-phosphate (cyclic AMP). Two biopsy specimens of colonic mucosa were obtained endoscopically before and after different periods of therapy (5, 10, or 15 days), from each of 21 patients receiving chenodeoxycholic acid. A rise of cyclic AMP intracellular levels was found, but only after 5 and 10 days of treatment was the increase statistically significant when compared with basal levels. Similar changes were observed for guanosine 3':5'-phosphate (cyclic GMP), but percentage increases were higher than for cyclic AMP. Initial diarrhea disappeared spontaneously, and at 15 days the levels of both cyclic nucleotides were not significantly different from basal levels. These findings suggest that colonic adaptation to increase in luminal bile salt levels is related to changes in intracellular levels of cyclic nucleotides and support the hypothesis that not only cyclic AMP, but also cyclic GMP may play an important role in producing bile salt-induced diarrhea in man.

Cite

CITATION STYLE

APA

Corazza, G. R., Ciccarelli, R., Caciagli, F., & Gasbarrini, G. (1979). Cyclic AMP and cyclic GMP levels in human colonic mucosa before and during chenodeoxycholic acid therapy. Gut, 20(6), 489–492. https://doi.org/10.1136/gut.20.6.489

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free